These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27431531)

  • 1. Using the weighted area under the net benefit curve for decision curve analysis.
    Talluri R; Shete S
    BMC Med Inform Decis Mak; 2016 Jul; 16():94. PubMed ID: 27431531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision curve analysis confirms higher clinical utility of multi-domain versus single-domain prediction models in patients with open abdomen treatment for peritonitis.
    Huber M; Schober P; Petersen S; Luedi MM
    BMC Med Inform Decis Mak; 2023 Apr; 23(1):63. PubMed ID: 37024840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision curve analysis to evaluate the clinical benefit of prediction models.
    Vickers AJ; Holland F
    Spine J; 2021 Oct; 21(10):1643-1648. PubMed ID: 33676020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision curve analysis: a novel method for evaluating prediction models.
    Vickers AJ; Elkin EB
    Med Decis Making; 2006; 26(6):565-74. PubMed ID: 17099194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating a new marker for risk prediction: decision analysis to the rescue.
    Baker SG; Kramer BS
    Discov Med; 2012 Sep; 14(76):181-8. PubMed ID: 23021372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
    Barbieri CE; Cha EK; Chromecki TF; Dunning A; Lotan Y; Svatek RS; Scherr DS; Karakiewicz PI; Sun M; Mazumdar M; Shariat SF
    BJU Int; 2012 Mar; 109(5):685-90. PubMed ID: 21851550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Decision-Analysis Performances of Risk Prediction Models Using ADAPT Curves.
    Lee WC; Wu YC
    Medicine (Baltimore); 2016 Jan; 95(2):e2477. PubMed ID: 26765451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision Curve Analysis for Personalized Treatment Choice between Multiple Options.
    Chalkou K; Vickers AJ; Pellegrini F; Manca A; Salanti G
    Med Decis Making; 2023 Apr; 43(3):337-349. PubMed ID: 36511470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision Curve Analysis of In-Hospital Mortality Prediction Models: The Relative Value of Pre- and Intraoperative Data For Decision-Making.
    Huber M; Bello C; Schober P; Filipovic MG; Luedi MM
    Anesth Analg; 2024 Feb; ():. PubMed ID: 38315623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving multivariable prostate cancer risk assessment using the Prostate Health Index.
    Foley RW; Gorman L; Sharifi N; Murphy K; Moore H; Tuzova AV; Perry AS; Murphy TB; Lundon DJ; Watson RW
    BJU Int; 2016 Mar; 117(3):409-17. PubMed ID: 25847734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating a new marker for risk prediction using the test tradeoff: an update.
    Baker SG; Van Calster B; Steyerberg EW
    Int J Biostat; 2012 Mar; 8(1):. PubMed ID: 22499728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First things first: risk model performance metrics should reflect the clinical application.
    Kerr KF; Janes H
    Stat Med; 2017 Dec; 36(28):4503-4508. PubMed ID: 29156498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing Heterotopic Ossification in Combat Casualties-Which Models Are Best Suited for Clinical Use?
    Alfieri KA; Potter BK; Davis TA; Wagner MB; Elster EA; Forsberg JA
    Clin Orthop Relat Res; 2015 Sep; 473(9):2807-13. PubMed ID: 25917420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Net reclassification index at event rate: properties and relationships.
    Pencina MJ; Steyerberg EW; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
    Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
    Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Performance measures for prediction models and markers: evaluation of predictions and classifications].
    Steyerberg EW; Van Calster B; Pencina MJ
    Rev Esp Cardiol; 2011 Sep; 64(9):788-94. PubMed ID: 21763052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models.
    Verbakel JY; Steyerberg EW; Uno H; De Cock B; Wynants L; Collins GS; Van Calster B
    J Clin Epidemiol; 2020 Oct; 126():207-216. PubMed ID: 32712176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discriminative ability, reclassification and net benefit: the predictive value of biomarkers].
    Steyerberg EW; Pencina MJ; Van Calster B
    Ned Tijdschr Geneeskd; 2012; 156(41):A5029. PubMed ID: 23062255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.